Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies

Journal of Thoracic Oncology

Volumn 6, Issue 3, 2011, Pages 545-552

  Tselis, Nikolaos ^a   Ferentinos, Konstantinos ^a   Kolotas, Christos ^a,b   Schirren, Joachim ^c   Baltas, Dimos ^a   Antonakakis, Angela ^a   Ackermann, Hanns ^d   Zamboglou, Nikolaos ^a  

^a Klinikum Offenbach   (Germany)

^b Hirslanden Hospital   (Switzerland)

^c DR HORST SCHMIDT KLINIKEN   (Germany)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

CT guided interstitial brachytherapy; Intrathoracic malignancies; Local ablation

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LUNG LESION; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PNEUMOTHORAX; PRIMARY TUMOR; PRIORITY JOURNAL; SECOND CANCER; SOFT TISSUE SARCOMA; SURVIVAL RATE; TUMOR VOLUME;

EID: 79951768063     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318208c7a3     Document Type: Article

References (63)

1. Downey RJ, Ng KK. The management of non-small-cell lung cancer with oligometastases. Chest Surg Clin N Am 2001;11:121-132, review. (Pubitemid 32215728)
2. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995;13: 8-10.
3. The International Registry of Lung Metastases. Long-term results of lung metastasectomy: prognostic analysis based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37-49.
4. Mineo TC, Ambrogi V, Tonini G, et al. Pulmonary metastasectomy: might the type of resection affect survival? J Surg Oncol 2001;76:47-52. (Pubitemid 32128362)
5. King J, Glenn D, Clark W, et al. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg 2004;91:217-223. (Pubitemid 38233968)
6. Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology 2004; 231:850-857. (Pubitemid 38668108)
7. Steinke K, Sewell PE, Dupuy D, et al. Pulmonary radiofrequency ablation-an international study survey. Anticancer Res 2004;24:339-343. (Pubitemid 38279729)
8. Jin GY, Lee JM, Lee YC, et al. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. AJR Am J Roentgenol 2004;183:1013-1020. (Pubitemid 44185087)
9. Yan TD, King J, Sjarif A, et al. Learning curve for percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: a prospective study of 70 consecutive cases. Ann Surg Oncol 2006;13:1588-1595. (Pubitemid 44951466)
10. Vogl TJ, Fieguth HG, Eichler K, et al. [Laser-induced thermotherapy of lung metastases and primary lung tumors] Radiologe 2004;44:693-699. (Pubitemid 39062362)
11. Rosenberg C, Puls R, Hegenscheid K, et al. Laser ablation of metastatic lesions of the lung: long-term outcome. AJR Am J Roentgenol 2009; 192:785-792.
12. Kolotas C, Baltas D, Zamboglou N. CT based interstitial HDR Brachytherapy. Strahlenther Onkol 1999;175:419-427.
13. Imamura F, Ueno K, Kusunoki Y, et al. High-dose-rate brachytherapy for small-sized peripherally located lung cancer. Strahlenther Onkol 2006;182:703-707. (Pubitemid 44887171)
14. Kolotas C, Roddiger S, Strassmann G, et al. Palliative interstitial HDR brachytherapy for recurrent rectal cancer. Implantation techniques and results. Strahlenther Onkol 2003;179:458-463. (Pubitemid 36735774)
15. Zelefsky MJ, Zimberg SH, Raben A, et al. Brachytherapy for locally advanced and recurrent lymph node metastases. J Brachytherapy Int 1998;14:123-130.
16. Ricke J, Wust P, Stohlmann A, et al. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 2004;58:1496-1505. (Pubitemid 38438313)
17. Martin T, Baltas D, Kurek R, et al. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. Strahlenther Onkol 2004; 180:225-232. (Pubitemid 38461547)
18. Tselis N, Heyd R, Baghi M, et al. Interstitial high-dose-rate- brachytherapy in advanced esthesioneuroblastoma. Laryngoscope 2008;118:2006-2010.
19. Kolotas C, Tselis N, Sommerlad M, et al. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy. Strahlenther Onkol 2007;183:69-75.
20. Wieners G, Pech M, Rudzinska M, et al. CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies. Eur Radiol 2006;16:2586-2593. (Pubitemid 44649709)
21. Ricke J, Wust P, Wieners G, et al. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 2004;15:1279-1286. (Pubitemid 39487859)
22. Peters N, Wieners G, Pech M, et al. CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial. Strahlenther Onkol 2008;184:296-301. (Pubitemid 351806514)
23. Tsalpatouros A, Baltas D, Kolotas C, et al. CT based software for 3D localisation and reconstruction in stepping source brachytherapy. IEEE Trans Inf Technol Biomed 1997;1:229-242. (Pubitemid 127771008)
24. Kurek R, Kalogera-Fountzila A, Muskalla K, et al. Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer. Strahlenther Onkol 2003;179:292-297. (Pubitemid 36606019)
25. Park JO, Lee SI, Song SY, et al. Measuring response in solid tumors: comparison of RECIST and WHO response criteria. Jpn J Clin Oncol 2003;33:533-537. (Pubitemid 43115248)
26. Kaplan EW, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
27. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
28. Ernst-Stecken A, Lambrecht U, Mueller R, et al. Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a phase I/II study. Strahlenther Onkol 2006;182: 696-702. (Pubitemid 44887170)
29. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy- naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26:3543-3551.
30. Reck M, Macha HN, Del Barco S, et al. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma. Lung Cancer 2009;64:319-325.
31. Vokes EE, Herndon JE 2nd, Kelley MJ, et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: cancer and leukemia group B. J Clin Oncol 2007;25:1698-1704. (Pubitemid 46797950)
32. Caglar HB, Baldini EH, Othus M, et al. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. Cancer 2009;115:4156-4166.
33. Newlin HE, Iyengar M, Morris CG, et al. Unresectable squamous cell carcinoma of the lung: an outcomes study. Int J Radiat Oncol Biol Phys 2009;74:370-376.
34. Sura S, Gupta V, Yorke E, et al. Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan- Kettering Cancer Center (MSKCC) experience. Radiother Oncol 2008; 87:17-23.
35. Fong T, Morgensztern D, Govindan R. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer. J Thorac Oncol 2008; 3:303-310. (Pubitemid 351654331)
36. Kubota K, Nishiwaki Y, Tamura T, et al. Efficacy and safety of erlotinib monotherapy for Japanese patients with advanced non-small cell lung cancer: a phase II study. J Thorac Oncol 2008;3:1439-1445.
37. Lee CB, Stinchcombe TE, Moore DT, et al. Late complications of high-dose (- 66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer. J Thorac Oncol 2009;4:74-79.
38. Hosten N, Stier A, Weigel C, et al. [Laser-induced thermotherapy (LITT) of lung metastases: description of a miniaturized applicator, optimization, and initial treatment of patients]. Rofo 2003;175:393-400.
39. Willner J, Baier K, Caragiani E, et al. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002;52:382-389. (Pubitemid 34173001)
40. Martel MK, Ten Haken RK, Hazuka MB, et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 1999;24:31-37. (Pubitemid 29241815)
41. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-122.
42. Hamamoto Y, Kataoka M, Yamashita M, et al. Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer. Jpn J Clin Oncol 2010;40:125-129.
43. Timmerman RD, Park C, Kavanagh BD. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol 2007;2(Suppl 73):101-112.
44. Siva S, MacManus M, Ball D. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review. J Thorac Oncol 2010;5:1091-1099.
45. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 1998;82:1062-1070. (Pubitemid 28136518)
46. Onimaru R, Shirato H, Shimizu S, et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003;56:126-135. (Pubitemid 36403684)
47. Guckenberger M, Heilman K, Wulf J, et al. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. Radiother Oncol 2007;85:435-442. (Pubitemid 350213147)
48. Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004;60:186-196. (Pubitemid 39165484)
49. Yoon SM, Choi EK, Lee SW, et al. Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors. Acta Oncol 2006;45:1108-1114. (Pubitemid 44808498)
50. Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009;27:1579-1584.
51. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009;27:3290-3296.
52. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427-1431. (Pubitemid 41628038)
53. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833-4839. (Pubitemid 46630909)
54. Kim H, Ahn YC, Park HC, et al. Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer. J Thorac Oncol 2010;5:526-532.
55. Le QT, Loo BW, Ho A, et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 2006;1:802-809. (Pubitemid 47181385)
56. Nakagawa K, Aoki Y, Tago M, et al. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. Int J Radiat Oncol Biol Phys 2000;48:449-457.
57. Hara R, Itami J, Kondo T, et al. Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol 2002;63:159-163. (Pubitemid 34628404)
58. Wulf J, Baier K, Mueller G, et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 2005;77:83-87. (Pubitemid 41503394)
59. Fritz P, Kraus HJ, Mühlnickel W, et al. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol 2006;1:30.
60. Hof H, Hoess A, Oetzel D, et al. Stereotactic single-dose radiotherapy of lung metastases. Strahlenther Onkol 2007;183:673-678. (Pubitemid 350175409)
61. Keall PJ, Mageras GS, Balter JM, et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 2006;33:3874-3900. (Pubitemid 44505111)
62. Negoro Y, Nagata Y, Aoki T, et al. The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: reduction of respiratory tumor movement and evaluation of the daily setup accuracy. Int J Radiat Oncol Biol Phys 2001;50:889-898. (Pubitemid 32594831)
63. Ruggieri R, Naccarato S, Nahum AE. Severe hypofractionation: nonhomogeneous tumour dose delivery can counteract tumour hypoxia. Acta Oncol 2010;49:1304-1314.